DUSTIN KELLY: Open Payments
NPI 1942987664 · GRENADA, MS. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$660 in 30 payments from 10 companies in 2025. Trend: 2023 $50 · 2024 $519 · 2025 $660
Food & beverage: $660
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 16 | $235 |
| Alpha Cognition USA, Inc. | 1 | $143 |
| Lilly USA, LLC | 3 | $71 |
| Baxter Healthcare | 2 | $40 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 2 | $39 |
| Corcept Therapeutics | 2 | $37 |
| Inspire Medical Systems, Inc. | 1 | $32 |
| Novo Nordisk Inc | 1 | $26 |
| AstraZeneca Pharmaceuticals LP | 1 | $19 |
| Ardelyx, Inc. | 1 | $18 |
Products named: Zunveyl, QULIPTA, VRAYLAR, UBRELVY, Hillrom - Vest System Model 105 Home Care, CAPLYTA, Korlym, JARDIANCE.
Industry payments across MS — which companies pay providers there.
